Ivermount 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin exerts its effect by binding selectively to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. Ivermount 12 is indicated for the treatment of strongyloidiasis, onchocerciasis, and other susceptible parasitic infestations such as scabies and certain types of lice infestations. The tablet is administered orally, with dosage and duration tailored according to the specific infection and patient weight. Ivermectin is generally well tolerated; however, potential side effects may include dizziness, nausea, diarrhea, and mild skin reactions. It is contraindicated in patients with known hypersensitivity to ivermectin or any component of the formulation. Caution is advised in patients with impaired liver function or concomitant use of other medications metabolized through the cytochrome P450 system. Ivermount 12 should be used under medical supervision, with adherence to prescribed dosage to ensure efficacy and minimize the risk of resistance development. Pregnant and lactating women should consult a healthcare provider before use.